5 Top Stocks to Buy in 2024

CRISPR Therapeutics stock is trading at a much lower level than it did in the past, when we had less visibility about the future. Considering that this biotech is in the early stages of its story, over time, the shares could soar from today's level.

Eli Lilly . Eli Lilly Lilly is increasing production capacity, and in more good news, the company recently won regulatory approval for the same molecule to specifically address weight loss.

Vertex Pharmaceuticals (VRTX -1.03%) is known for its leadership in the global cystic fibrosis (CF) treatment market, and its CF drugs have brought in billions of dollars in earnings. This is set to continue into the next decade thanks to current products and a very promising candidate in pivotal development right now.

Intuitive Surgical (ISRG 1.40%) is the worldwide leader in robotic surgery, with its flagship da Vinci system now installed in 8,285 locations. What I like most about Intuitive is its moat, ocompetitive advantage, which should ensure ongoing market leadership.

Pfizer's (PFE -5.12%) revenue surged to record highs last year thanks to its coronavirus vaccine and treatment, but today, the big pharma faces two challenges: a decline in coronavirus product revenue and upcoming losses of exclusivity of certain older blockbusters.